Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (521-530 of 573) with videos related to

Pageof 58
Sort By:
Leukemia|June 1, 2002
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?M Breccia, M C Petti, A M Testi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
British Journal of Cancer|August 9, 2012
Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome studyF Efficace, M Baccarani, G Rosti, et al.
Experimental Hematology|July 31, 1999
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cellsA Tafuri, R M Lemoli, M T Petrucci, et al.
European Journal of Haematology|December 17, 1998
Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative GroupA Pulsoni, A Stazi, R Cotichini, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Blood|July 29, 1998
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" TrialD Diverio, V Rossi, G Avvisati, et al.
Letters in Applied Microbiology|March 28, 2013
The characterization of a thermostable and cambialistic superoxide dismutase from Thermus filiformisF Mandelli, J P L Franco Cairo, A P S Citadini, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Leukemia|January 17, 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trialS Keating, S Suciu, T de Witte, et al.
Pageof 58

Showing results (521-530 of 573) with videos related to

Sort By:
Pageof 58
Leukemia|June 1, 2002
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?M Breccia, M C Petti, A M Testi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
British Journal of Cancer|August 9, 2012
Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome studyF Efficace, M Baccarani, G Rosti, et al.
Experimental Hematology|July 31, 1999
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cellsA Tafuri, R M Lemoli, M T Petrucci, et al.
European Journal of Haematology|December 17, 1998
Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative GroupA Pulsoni, A Stazi, R Cotichini, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Blood|July 29, 1998
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" TrialD Diverio, V Rossi, G Avvisati, et al.
Letters in Applied Microbiology|March 28, 2013
The characterization of a thermostable and cambialistic superoxide dismutase from Thermus filiformisF Mandelli, J P L Franco Cairo, A P S Citadini, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Leukemia|January 17, 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trialS Keating, S Suciu, T de Witte, et al.
Pageof 58